N-Acetyl Cysteine (NAC): Clinical Evidence & Substantiation Summary
What Is N-Acetyl Cysteine (NAC)?
NAC is a precursor to glutathione, the body's master antioxidant. It has broad clinical applications including respiratory health, liver protection, mental health, and immune function. Its use in supplement form was briefly challenged by FDA in 2020 but has since been resolved.
Mechanism of action: NAC donates a cysteine molecule for glutathione synthesis, the body's primary endogenous antioxidant. It breaks disulfide bonds in mucus (mucolytic effect), chelates heavy metals, modulates glutamate signalling via the cystine-glutamate antiporter, and inhibits NF-κB activation.
Clinical Evidence Summary
Below are 3 key clinical studies on N-Acetyl Cysteine (NAC). Nutra Comp analyses 72+ studies in its full clinical evidence report.
NAC for prevention of COPD exacerbations: a meta-analysis
Population: 13 RCTs, 4,155 patients
Key finding: NAC (≥1,200 mg/day) significantly reduced COPD exacerbation frequency by 25% (RR 0.75, 95% CI 0.62–0.92).
NAC and mental health: a systematic review
Population: 16 RCTs
Key finding: NAC showed significant benefits as adjunctive treatment for depression (SMD: -0.37, p=0.001), OCD, and addiction disorders.
NAC supplementation and oxidative stress markers
Population: 9 RCTs
Key finding: NAC significantly increased total antioxidant capacity (p=0.002) and glutathione levels (p<0.001) while reducing MDA (a lipid peroxidation marker).
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for N-Acetyl Cysteine (NAC)
Includes all 72+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is NAC FDA approved?
NAC is approved as an OTC drug (Mucomyst) and was briefly challenged as a supplement. FDA issued enforcement discretion guidance in 2022, allowing continued sale as a dietary supplement.
What are the most studied benefits?
The strongest evidence supports NAC for glutathione support, respiratory health (reducing COPD exacerbations), and as adjunctive support in mental health conditions.
What dosage is used in clinical studies?
Most studies use 600–1,800 mg/day, divided into 2–3 doses. The respiratory meta-analysis found 1,200 mg/day as the minimum effective dose.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist